Seckel syndrome exhibits cellular features demonstrating defects in the ATR-signalling pathway
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
To date, the only reported genetic defect identified in the developmental disorder, Seckel syndrome, is a mutation in ataxia telangiectasia and Rad3-related protein (ATR). Seckel syndrome is clinically and genetically heterogeneous and whether defects in ATR significantly contribute to Seckel syndrome is unclear. Firstly, we characterize ATR-Seckel cells for their response to DNA damage. ATR-Seckel cells display impaired phosphorylation of ATR-dependent substrates, impaired G2/M checkpoint arrest and elevated micronucleus (MN) formation following exposure to UV and agents that cause replication stalling. We describe a novel phenotype, designated nuclear fragmentation (NF), that occurs following replication arrest. Finally, we report that ATR-Seckel cells have an endogenously increased number of centrosomes in mitotic cells demonstrating a novel role for ATR in regulating centrosome stability. We exploit these phenotypes to examine cell lines derived from additional unrelated Seckel syndrome patients. We show that impaired phosphorylation of ATR-dependent substrates is a common but not invariant feature of Seckel syndrome cell lines. In contrast, all cell lines displayed defective G2/M arrest, increased levels of NF and MN formation following exposure to agents that cause replication stalling. All the Seckel syndrome cell lines examined showed increased endogenous centrosome numbers. Though ATR cDNA can complement the defects in ATR-Seckel cells, it failed to complement any of the additional cell lines. We conclude that Seckel syndrome represents a further damage response disorder that is uniquely associated with defects in the ATR-signalling pathway resulting in failed checkpoint arrest following exposure to replication fork stalling.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The DNA damage response: putting checkpoints in perspective
Zhou, B.-B. S., & Elledge, S. J. (2000) · Nature · doi:10.1038/35044005 · Cited by 3,213
Sensing DNA Damage Through ATRIP Recognition of RPA-ssDNA Complexes
Zou, L., & Elledge, S. J. (2003) · Science · doi:10.1126/science.1083430 · Cited by 2,693 · cited 1×
“It is thought that RPA coating of single-strand regions of DNA results in ATR/ATRIP complex recruitment (3,4).”
BackgroundLiu, Q., Guntuku, S., Cui, X.-S., Matsuoka, S., Cortez, D., Tamai, K., Luo, G., Carattini-Rivera, S., DeMayo, F., Bradley, A., et al. (2000) · Genes & Development · doi:10.1101/gad.14.12.1448 · Cited by 1,625 · cited 2×
“Chk1, a substrate of ATR, plays a critical role in establishing arrest at these checkpoints ( 6 ,8).”
BackgroundHistone H2AX is phosphorylated in an ATR-dependent manner in response to replicational stress
Ward, I. M., & Chen, J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c100569200 · Cited by 1,150
ATR-Mediated Checkpoint Pathways Regulate Phosphorylation and Activation of Human Chk1
Zhao, H., & Piwnica-Worms, H. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.13.4129-4139.2001 · Cited by 1,091 · cited 1×
“Chk1, a substrate of ATR, plays a critical role in establishing arrest at these checkpoints (6,8).”
BackgroundA role for ATR in the DNA damage-induced phosphorylation of p53
Tibbetts, R. S., Brumbaugh, K. M., Williams, J. M., Sarkaria, J. N., Cliby, W. A., Shieh, S.-Y., Taya, Y., Prives, C., & Abraham, R. T. (1999) · Genes & Development · doi:10.1101/gad.13.2.152 · Cited by 1,046 · cited 1×
“The ability of ATR to phosphorylate p53 indicates that ATR likely also regulates damage-induced apoptosis (7).”
BackgroundHistone H2AX phosphorylation is dispensable for the initial recognition of DNA breaks
Celeste, A., Fernandez-Capetillo, O., Kruhlak, M. J., Pilch, D. R., Staudt, D. W., Lee, A., Bonner, R. F., Bonner, W. M., & Nussenzweig, A. (2003) · Nature Cell Biology · doi:10.1038/ncb1004 · Cited by 989 · cited 1×
“Phosphorylation of H2AX, a variant form of the histone H2A, is one of the earliest events in the damage response and appears to be required for the retention of additional damage response proteins at the site of the damage (10).”
BackgroundATR and ATRIP: Partners in Checkpoint Signaling
Cortez, D., Guntuku, S., Qin, J., & Elledge, S. J. (2001) · Science · doi:10.1126/science.1065521 · Cited by 985
ATR disruption leads to chromosomal fragmentation and early embryonic lethality
Brown, E. J., & Baltimore, D. (2000) · Genes & Development · doi:10.1101/gad.14.4.397 · Cited by 951 · cited 1×
“Unlike ATM, however, ATR is essential for both embryonic development and somatic cell growth (2,14,15).”
Background14-3-3σ is required to prevent mitotic catastrophe after DNA damage
Chan, T. A., Hermeking, H., Lengauer, C., Kinzler, K. W., & Vogelstein, B. (1999) · Nature · doi:10.1038/44188 · Cited by 895
Cited by
ATM and ATR as therapeutic targets in cancer
Weber, A. M., & Ryan, A. J. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.12.001 · Cited by 635
The role of double-strand break repair — insights from human genetics
O'Driscoll, M., & Jeggo, P. A. (2006) · Nature Reviews Genetics · doi:10.1038/nrg1746 · Cited by 583
Self-citationThe ATM-mediated DNA-damage response: taking shape
Shiloh, Y. (2006) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2006.05.004 · Cited by 541
Stiff, T., Walker, S. A., Cerosaletti, K., Goodarzi, A. A., Petermann, E., Concannon, P., O'Driscoll, M., & Jeggo, P. A. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601446 · Cited by 360
“Previously, we found that analysis of mitotic index (MI) after UV treatment is an efficient monitor of G2/M arrest (Alderton et al, 2004; Stiff et al, 2005).”
BackgroundSelf-citationMutations in pericentrin cause Seckel syndrome with defective ATR-dependent DNA damage signaling
Griffith, E., Walker, S., Martin, C.-A., Vagnarelli, P., Stiff, T., Vernay, B., Sanna, N. A., Saggar, A., Hamel, B., Earnshaw, W. C., et al. (2008) · Nature Genetics · doi:10.1038/ng.2007.80 · Cited by 302
Self-citationWeston, V. J., Oldreive, C. E., Skowronska, A., Oscier, D. G., Pratt, G., Dyer, M. J. S., Smith, G., Powell, J. E., Rudzki, Z., Kearns, P., et al. (2010) · Blood · doi:10.1182/blood-2010-01-265769 · Cited by 300
Cdk5rap2 exposes the centrosomal root of microcephaly syndromes
Megraw, T. L., Sharkey, J. T., & Nowakowski, R. S. (2011) · Trends in Cell Biology · doi:10.1016/j.tcb.2011.04.007 · Cited by 124
“SCKL cells, whether mutant in ATR or other genes, exhibit centrosome amplification [67].”
BackgroundVrouwe, M. G., Pines, A., Overmeer, R. M., Hanada, K., & Mullenders, L. H. F. (2011) · Journal of Cell Science · doi:10.1242/jcs.075325 · Cited by 100
Kerzendorfer, C., & O’Driscoll, M. (2009) · DNA Repair · doi:10.1016/j.dnarep.2009.04.018 · Cited by 97
Self-citationDNA repair mechanisms protect our genome from carcinogenesis
Moraes, M. C. S. (2012) · Frontiers in Bioscience · doi:10.2741/3992 · Cited by 64
“Interestingly, even cells from patients not mutated in this gene are defective in the ATR-pathway function (71).”
BackgroundThe DNA damage response: balancing the scale between cancer and ageing.
Seviour, E. G., & Lin, S.-Y. (2010) · Aging · doi:10.18632/aging.100248 · Cited by 61
“Humans surviving with ATR mutations display a condition called Seckel syndrome, the phenoltype of which includes growth retardation and microcephaly [21].”
BackgroundThe methyl methanesulfonate induced S-phase delay in XRCC1-deficient cells requires ATM and ATR
Brem, R., Fernet, M., Chapot, B., & Hall, J. (2008) · DNA Repair · doi:10.1016/j.dnarep.2008.02.002 · Cited by 20
ATR controls the p21WAF1/Cip1 protein up‐regulation and apoptosis in response to low UV fluences
Al‐Khalaf, H. H., Hendrayani, S., & Aboussekhra, A. (2012) · Molecular Carcinogenesis · doi:10.1002/mc.20864 · Cited by 13
Metadata
- Authors
- Alderton, G. K., Joenje, H., Varon, R., Børglum, A. D., Jeggo, P. A., & O'Driscoll, M.
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-10-20
- Volume
- 13
- Issue
- 24
- Pages
- 3127-3138
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- OpenAlex
- W2167545422
- Cited by
- 176
- References
- 16
- FWCI
- 4.05
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.